Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumoniaBMC Microbiology, 2012
- Triple combinations of neuraminidase inhibitors, statins and fibrates benefit the survival of patients with lethal avian influenza pandemicMedical Hypotheses, 2011
- Simvastatin pretreatment prevents ambient particle-induced lung injury in miceInhalation Toxicology, 2011
- Pre-Admission Statin Use and In-Hospital Severity of 2009 Pandemic Influenza A(H1N1) DiseasePLOS ONE, 2011
- Host Defense against Viral Infection Involves Interferon Mediated Down-Regulation of Sterol BiosynthesisPLOS Biology, 2011
- Pathogenesis of Pandemic Influenza A (H1N1) and Triple-Reassortant Swine Influenza A (H1) Viruses in MiceJournal of Virology, 2010
- Susceptibility of Highly Pathogenic H5N1 Influenza Viruses to the Neuraminidase Inhibitor Oseltamivir Differs In Vitro and in a Mouse ModelAntimicrobial Agents and Chemotherapy, 2009
- Increased Survival after Gemfibrozil Treatment of Severe Mouse InfluenzaAntimicrobial Agents and Chemotherapy, 2007
- Influenza and COPD Mortality Protection as Pleiotropic, Dose-Dependent Effects of StatinsChest, 2007
- Pandemic Influenza: A Potential Role for Statins in Treatment and ProphylaxisClinical Infectious Diseases, 2006